MedPath

浙江永太药业有限公司

Ownership
-
Established
2012-07-13
Employees
-
Market Cap
-
Website
http://yontapharma.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20253481
Approval Date
Mar 4, 2025
NMPA

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20253482
Approval Date
Mar 4, 2025
NMPA

Sitagliptin Phosphate and Metformin Hydrochloride Tablets (Ⅰ)

Product Name
西格列汀二甲双胍片(Ⅰ)
Approval Number
国药准字H20253198
Approval Date
Jan 14, 2025
NMPA

Sitagliptin Phosphate and Metformin Hydrochloride Tablets (Ⅱ)

Product Name
西格列汀二甲双胍片(Ⅱ)
Approval Number
国药准字H20253199
Approval Date
Jan 14, 2025
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244050
Approval Date
Jun 18, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244051
Approval Date
Jun 18, 2024
NMPA

Moxifloxacin Hydrochloride Tablets

Product Name
盐酸莫西沙星片
Approval Number
国药准字H20244077
Approval Date
Jun 18, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244049
Approval Date
Jun 18, 2024
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20243920
Approval Date
Jun 4, 2024
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20243919
Approval Date
Jun 4, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.